Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission.

Natasha N PettitCynthia T NguyenAlison K LewPalak H BhagatAllison NelsonGregory OlsonJessica P RidgwayMai T PhoJade Pagkas-Bather

Published in: BMC infectious diseases (2021)

Following the implementation of a guideline outlining recommendations for initiating and discontinuing antibiotics for CABP among COVID-19 inpatients, we observed a reduction in antibiotic prescribing and DOT. The guideline also resulted in a significant increase in the rate of guideline-congruent empiric antibiotic initiation.

Keyphrases

coronavirus disease
sars cov
primary care
healthcare
emergency department
adverse drug
urinary tract infection
stem cells
quality improvement
energy transfer